IL-21は,抗原活性化MAIT細胞の細胞毒性を選択的に増加させる
Laura E Wedlock1, Rajesh Lamichhane1, Meg C Webley1
1Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
European journal of immunology
|February 19, 2026
まとめ
インターリューキン-21 (IL-21) は,粘膜関連インヴァリアントT細胞 (MAIT) の細胞毒性を高めます. このサイトカインは,Granzyme BとPerforinのMAIT細胞発現を促進し,感染した細胞を排除する能力を向上させます.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
- 微生物学 微生物学とは
背景:
- 粘膜関連インヴァリアントT細胞 (MAIT) は,MR1.1経由で微生物の代謝産物を認識する非常規のT細胞です.
- MAIT細胞の活性化は,T細胞受容体 (TCR) のエンゲージメントまたはサイトカインシグナル伝達 (IL-12/IL-18) により発生する.
- 活性化すると,MAIT細胞は,感染した細胞を排除するために,グラン酵素Bやパーフェリンなどの細胞毒性分子を放出しますが,この細胞毒性を調節するサイトカインの役割は不明です.
研究 の 目的:
- MAIT細胞の細胞毒性を調節するサイトカインインターリューキン-21 (IL-21) の特定の役割を調査する.
- IL-21が細胞毒性分子の発現とMAIT細胞の殺戮能力に影響するかどうかを判断する.
主な方法:
- MAIT細胞はTCRまたはIL-12/IL-18シグナル伝達によって活性化されました.
- MAIT細胞のグラン酵素Bとパーフェリン発現に対するIL-21プライミングの効果を評価した.
- フローサイトメトリーベースの細胞毒性アッセイを使用して,標的細胞のMAIT細胞破壊を測定しました (5-OP-RUで処理されたB細胞系).
主要な成果:
- IL-21は,TCRまたはIL-12/IL-18で活性化されたMAIT細胞におけるグラン酵素Bおよびパーフェリンの発現を著しく強化した.
- IL-21はMAIT細胞のサイトカイン生成に最小限の影響を及ぼしました.
- IL-21のプライミングは,バクテリアの抗原を提示する細胞に対するMAIT細胞の細胞毒性を改善しました.
結論:
- IL-21は,MAIT細胞の細胞毒性を選択的に増加させる共刺激分子として作用します.
- この発見は,微生物感染症に対するMAIT細胞媒介免疫を強化するIL-21の新たな役割を強調しています.
関連する概念動画
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
T Cell Types and Functions
2.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
Antigens Involved in Adaptive Immunity
1.6K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
Cell-mediated Immune Responses
84.6K
Overview
84.6K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K


